Abstract
The clinicians should be alerted about the development of serious adverse events related to RDV administration. In particular, strict monitoring of cardiac rhythm and liver function is crucial. Further well-designed clinical trials, evaluating RDV benefit-risk ratio for COVID-19 patients, are needed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Cytokines Their Relation with Mineral Dust Induced Diseases
Paper Title
Journal
Date
